HABP2 and neoplasm: Rousso-Noori et al. have identified the p32/gC1qR/HABP/C1qBP as a specific tumor-associated antigen expressed on the surface of glioma cells, resulting a feasible target for CAR T cell therapy with ability to control tumor growth in orthotopic syngeneic and xenograft mouse models.